CKLIFE SCIENCES: Monthly Return for Equity Issuer on Movements in Securities for the month ended 30 April 2024
May 2 04:49 ET
CKLIFE SCIENCES: Sustainability Report 2023
Apr 18 05:14 ET
CKLIFE SCIENCES: Notification Letter to Registered Holder - Annual General Meeting
Apr 18 04:58 ET
CKLIFE SCIENCES: Proxy Form
Apr 18 04:55 ET
CKLIFE SCIENCES: BUSINESS UPDATE ON PRECLINICAL STUDIES OF CANCER VACCINES TARGETING KRAS AND PD-L1 AND THE PROGRESS OF RESEARCH COLLABORATION WITH XTALPI
Apr 5 00:05 ET
CKLIFE SCIENCES: Monthly Return for Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 2 07:00 ET
CKLIFE SCIENCES: Terms of Reference of the Sustainability Committee
Mar 13 05:12 ET
CKLIFE SCIENCES: Monthly Return for Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 4 04:07 ET
CKLIFE SCIENCES: Terms of Reference of the Nomination Committee
Feb 21 06:32 ET
CKLIFE SCIENCES: Terms of Reference of the Remuneration Committee
Feb 21 06:27 ET
CKLIFE SCIENCES: Terms of Reference of the Audit Committee
Feb 21 06:21 ET
CKLIFE SCIENCES: Monthly Return for Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 1 04:03 ET
CKLIFE SCIENCES: Request Form for Non-registered Holder
Jan 16 05:23 ET
CKLIFE SCIENCES: Notification Letter to Non-registered Holder - New Arrangements for Dissemination of Corporate Communications
Jan 16 05:22 ET
CKLIFE SCIENCES: Request Form for Registered Holder
Jan 16 05:21 ET
CKLIFE SCIENCES: Notification Letter to Registered Holder - New Arrangements for Dissemination of Corporate Communications to Shareholders
Jan 16 05:20 ET
CKLIFE SCIENCES: Monthly Return for Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 2 04:41 ET
CKLIFE SCIENCES: Monthly Return for Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 1, 2023 04:36 ET
CKLIFE SCIENCES: Monthly Return for Equity Issuer on Movements in Securities for the month ended 31 October 2023
Nov 1, 2023 05:09 ET
CKLIFE SCIENCES: BUSINESS UPDATE ON PRECLINICAL STUDY OF PRAME AND PD-L1 DUAL-ANTIGEN CANCER VACCINES
Nov 1, 2023 00:00 ET
No Data
No Data